ClinicalTrials.Veeva

Menu
U

University of North Carolina at Chapel Hill | Lineberger Comprehensive Cancer Center

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Atezolizumab
Fludarabine
Cyclophosphamide
Talazoparib
Sacituzumab
Dexamethasone
Levonorgestrel
Vemurafenib
Ipilimumab

Parent organization

This site is a part of University of North Carolina at Chapel Hill

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 16 total trials

A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

The purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma...

Enrolling
Central Nervous System Lymphoma
Drug: Acalabrutinib
Drug: Isavuconazole
Locations recently updated

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called cemipli...

Enrolling
Melanoma
Drug: Pembrolizumab
Drug: Fianlimab

This is a phase 1, single-center, open-label study that enrolls adult subjects with extensive stage lung cancer or stage IV non-small cell lung cance...

Enrolling
Lung Cancer
Non Small Cell Lung Cancer
Biological: iC9.GD2.CAR.IL-15 T Infusion

This research study aims to evaluate the safety and effectiveness of the combination of isatuximab, pomalidomide, and dexamethasone (Isa-Pd) for the...

Enrolling
Aging
Multiple Myeloma
Drug: Pomalidomide
Drug: Isatuximab

Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to ris...

Enrolling
Endometrial Cancer
Metastasis
Drug: ONC201
Drug: Atezolizumab

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surg...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling
Multiple Myeloma
Advanced Solid Tumors
Drug: Trastuzumab and Pertuzumab
Drug: Palbociclib

Trial sponsors

UNC Lineberger Comprehensive Cancer Center logo
Gilead Sciences logo
Regeneron Pharmaceuticals logo
T
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems